HIAB CORPORATION | Stock Exchange Release | 08 June 2026 15:00:00 EEST
Members of Hiab Corporation’s (“Hiab” or the “Company”) Shareholders’ Nomination Board (“Nomination Board”) have been appointed.
The Nomination Board consists of four (4) members. According to the Charter of the Nomination Board, the members of the Nomination Board are appointed as follows: the two largest shareholders of class A shares are entitled to appoint one (1) member each, and the two largest shareholders of class B shares who do not own any class A shares, are entitled to appoint one (1) member each.
The number of votes held by each shareholder of all shares in the Company are determined based on the shareholders’ register of Hiab as per the situation on the first banking day of June each year. If a shareholder does not exercise their right to appoint a member, the right will be transferred to the next largest shareholder of A shares or shareholder of B Shares, who does not own any A shares, who would not otherwise have this right.
In accordance with the above, composition of the Nomination Board as of 8 June 2026 is the following:
In accordance with the Charter of the Nomination Board, the Chair of Hiab’s Board of Directors, Jukka Moisio, participates in the Nomination Board’s work as an expert without having the right to participate in the decision-making of the Nomination Board.
The Nomination Board is responsible for preparing proposals to the Annual General Meeting, and if necessary, to the Extraordinary General Meeting of Hiab, on the number, election and remuneration of the members of the Board of Directors. The Nomination Board shall submit its proposals to the Company’s Board of Directors no later than on the last day of January preceding the Annual General Meeting.
Further information on the Nomination Board is available on Hiab’s website at www.hiabgroup.com/governance.
For further information, please contact:
Taina Tirkkonen, EVP, General Counsel, tel. +358 50 317 4000
Aki Vesikallio, Vice President, Investor Relations, tel. +358 40 729 1670